Cargando…
Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is progressive and irreversible chronic lung inflammatory disease. Cigarette smoke, the main cause of COPD, is often associated with double-stranded DNA release which potentially activates DNA-sensing pathways, such as STING. This study, there...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321631/ https://www.ncbi.nlm.nih.gov/pubmed/37406004 http://dx.doi.org/10.1371/journal.pone.0284061 |
_version_ | 1785068653576716288 |
---|---|
author | Mdkhana, Bushra Saheb Sharif-Askari, Narjes Ramakrishnan, Rakhee K. Al-Sheakly, Baraa Khalid Hafezi, Shirin Saheb Sharif-Askari, Fatemeh Bajbouj, Khuloud Hamid, Qutayba Halwani, Rabih |
author_facet | Mdkhana, Bushra Saheb Sharif-Askari, Narjes Ramakrishnan, Rakhee K. Al-Sheakly, Baraa Khalid Hafezi, Shirin Saheb Sharif-Askari, Fatemeh Bajbouj, Khuloud Hamid, Qutayba Halwani, Rabih |
author_sort | Mdkhana, Bushra |
collection | PubMed |
description | BACKGROUND: Chronic obstructive pulmonary disease (COPD) is progressive and irreversible chronic lung inflammatory disease. Cigarette smoke, the main cause of COPD, is often associated with double-stranded DNA release which potentially activates DNA-sensing pathways, such as STING. This study, therefore, analyzed the role of STING pathway in inducing pulmonary inflammation, steroid resistance, and remodeling in COPD. METHODS: Primary cultured lung fibroblasts were isolated from healthy non-smoker, healthy smoker, and smoker COPD individuals. The expression of STING pathway, remodeling, and steroid resistance signatures were investigated in these fibroblasts upon LPS stimulation and treatment with dexamethasone and/or STING inhibitor, at both mRNA and protein levels using qRT-PCR, western blot, and ELISA. RESULTS: At baseline, STING was elevated in healthy smoker fibroblasts and to a higher extent in smoker COPD fibroblasts when compared to healthy non-smoker fibroblasts. Upon using dexamethasone as monotherapy, STING activity was significantly inhibited in healthy non-smoker fibroblasts but showed resistance in COPD fibroblasts. Treating both healthy and COPD fibroblasts with STING inhibitor in combination with dexamethasone additively inhibited STING pathway in both groups. Moreover, STING stimulation triggered a significant increase in remodeling markers and a reduction in HDAC2 expression. Interestingly, treating COPD fibroblasts with the combination of STING inhibitor and dexamethasone alleviated remodeling and reversed steroid hyporesponsiveness through an upregulation of HDAC2. CONCLUSION: These findings support that STING pathway plays an important role in COPD pathogenesis, via inducing pulmonary inflammation, steroid resistance, and remodeling. This raises the possibility of using STING inhibitor as a potential therapeutic adjuvant in combination with common steroid treatment. |
format | Online Article Text |
id | pubmed-10321631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-103216312023-07-06 Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease Mdkhana, Bushra Saheb Sharif-Askari, Narjes Ramakrishnan, Rakhee K. Al-Sheakly, Baraa Khalid Hafezi, Shirin Saheb Sharif-Askari, Fatemeh Bajbouj, Khuloud Hamid, Qutayba Halwani, Rabih PLoS One Research Article BACKGROUND: Chronic obstructive pulmonary disease (COPD) is progressive and irreversible chronic lung inflammatory disease. Cigarette smoke, the main cause of COPD, is often associated with double-stranded DNA release which potentially activates DNA-sensing pathways, such as STING. This study, therefore, analyzed the role of STING pathway in inducing pulmonary inflammation, steroid resistance, and remodeling in COPD. METHODS: Primary cultured lung fibroblasts were isolated from healthy non-smoker, healthy smoker, and smoker COPD individuals. The expression of STING pathway, remodeling, and steroid resistance signatures were investigated in these fibroblasts upon LPS stimulation and treatment with dexamethasone and/or STING inhibitor, at both mRNA and protein levels using qRT-PCR, western blot, and ELISA. RESULTS: At baseline, STING was elevated in healthy smoker fibroblasts and to a higher extent in smoker COPD fibroblasts when compared to healthy non-smoker fibroblasts. Upon using dexamethasone as monotherapy, STING activity was significantly inhibited in healthy non-smoker fibroblasts but showed resistance in COPD fibroblasts. Treating both healthy and COPD fibroblasts with STING inhibitor in combination with dexamethasone additively inhibited STING pathway in both groups. Moreover, STING stimulation triggered a significant increase in remodeling markers and a reduction in HDAC2 expression. Interestingly, treating COPD fibroblasts with the combination of STING inhibitor and dexamethasone alleviated remodeling and reversed steroid hyporesponsiveness through an upregulation of HDAC2. CONCLUSION: These findings support that STING pathway plays an important role in COPD pathogenesis, via inducing pulmonary inflammation, steroid resistance, and remodeling. This raises the possibility of using STING inhibitor as a potential therapeutic adjuvant in combination with common steroid treatment. Public Library of Science 2023-07-05 /pmc/articles/PMC10321631/ /pubmed/37406004 http://dx.doi.org/10.1371/journal.pone.0284061 Text en © 2023 Mdkhana et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Mdkhana, Bushra Saheb Sharif-Askari, Narjes Ramakrishnan, Rakhee K. Al-Sheakly, Baraa Khalid Hafezi, Shirin Saheb Sharif-Askari, Fatemeh Bajbouj, Khuloud Hamid, Qutayba Halwani, Rabih Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease |
title | Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease |
title_full | Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease |
title_fullStr | Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease |
title_full_unstemmed | Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease |
title_short | Nucleic acid sensor STING drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease |
title_sort | nucleic acid sensor sting drives remodeling and its inhibition enhances steroid responsiveness in chronic obstructive pulmonary disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321631/ https://www.ncbi.nlm.nih.gov/pubmed/37406004 http://dx.doi.org/10.1371/journal.pone.0284061 |
work_keys_str_mv | AT mdkhanabushra nucleicacidsensorstingdrivesremodelinganditsinhibitionenhancessteroidresponsivenessinchronicobstructivepulmonarydisease AT sahebsharifaskarinarjes nucleicacidsensorstingdrivesremodelinganditsinhibitionenhancessteroidresponsivenessinchronicobstructivepulmonarydisease AT ramakrishnanrakheek nucleicacidsensorstingdrivesremodelinganditsinhibitionenhancessteroidresponsivenessinchronicobstructivepulmonarydisease AT alsheaklybaraakhalid nucleicacidsensorstingdrivesremodelinganditsinhibitionenhancessteroidresponsivenessinchronicobstructivepulmonarydisease AT hafezishirin nucleicacidsensorstingdrivesremodelinganditsinhibitionenhancessteroidresponsivenessinchronicobstructivepulmonarydisease AT sahebsharifaskarifatemeh nucleicacidsensorstingdrivesremodelinganditsinhibitionenhancessteroidresponsivenessinchronicobstructivepulmonarydisease AT bajboujkhuloud nucleicacidsensorstingdrivesremodelinganditsinhibitionenhancessteroidresponsivenessinchronicobstructivepulmonarydisease AT hamidqutayba nucleicacidsensorstingdrivesremodelinganditsinhibitionenhancessteroidresponsivenessinchronicobstructivepulmonarydisease AT halwanirabih nucleicacidsensorstingdrivesremodelinganditsinhibitionenhancessteroidresponsivenessinchronicobstructivepulmonarydisease |